MILWAUKEE, WI, November 09, 2010 (Press-News.org) Innovative Custom Products, Inc. (ICP), owner of CureCeuticals, announced today its new invention, CureCeuticals' All-Natural Kills Ticks Specimen Drops.
According to Sherry Williams, Vice President, CureCeuticals' All-Natural Kills Ticks Specimen Drops start working on contact and kill a tick in about 90 seconds. She said the product contains no DEET, no chemicals, no synthetic ingredients and is completely safe. It comes in a small, convenient pocket-size vial that doubles as a "tick specimen receptacle". Williams said the product is simple to use, safe and effective. One drop directly on the tick disables the tick in seconds causing it to "release" and within 90 seconds the tick is dead. The tick is then placed in the vial as a "Tick Specimen" for a doctor's examination in case of tick disease or infection. Once the tick is placed in the vial, it should be disposed of safely and properly or brought to a doctor for examination.
The company also offers a safe and all-natural skin and surface spray, CureCeuticals' All-Natural Ticks Off Spray, used as a pre-post treatment for humans and animals who frequent wooded areas or farms, and it can also be applied to the skin immediately after removal of a tick. It can also be sprayed on carpets, clothes, and over the entire body. Williams said that both products contain the company's proprietary all-natural Citro-V Manuka Honey blend. Manuka Honey is scientifically proven for its antibacterial, antimicrobial, antiseptic, and anti-MRSA (Methicillin Rresistant Staphylococcus Aureus, a bacterial infection that is highly resistant to some antibiotics) properties. To learn more, visit http://bio.waikato.ac.nz/honey/.
According to Williams, ticks carry various diseases, are annoying parasites, and are difficult to kill without the use of potentially toxic and deadly chemicals. Our research identified no other all-natural, chemical-free commercially available product that is as safe and effective as CureCeuticals' All-Natural Kills Ticks Specimen Drops. The product is 100% natural, contains no DEET, environmentally friendly, safe and bio-degradable.
Williams said that international distributors are being assigned for worldwide distribution but in the mean time, the product is available in a 3-pack vial for $14.95 and can be purchased at the company's online store www.drmistICP.com and will be available at Amazon.com:
http://www.amazon.com/gp/search/ref=sr_nr_seeall_16?rh=k%3Acureceutic ... 1288991276
She said CureCeuticals' All-Natural Kills Ticks Drops is currently being presented to retail and sports stores, mass merchants, and pet stores nationwide and should soon be available at the register check-out lane for about $4.99 a vial. The company's companion product, CureCeuticals' All-Natural Ticks Off Spray retails for $16.95 for a 12-ounce bottle and is also available at the company's online store and at Amazon. The company expects robust sales for both products and is ramping up production to meet the anticipated demand.
CureCeuticals is a brand owned by Innovative Custom Products, Inc. (ICP), a Wisconsin corporation in business since 1992, and a distributor of consumer natural pharmaceutical and skin care products and can be contacted at: contact@icpCorporation.com or at (414) 358-1802 or visit the corporate website www.icpCorporation.com.
CureCeuticals Invents All-Natural Kills Ticks Drops: One Drop Kills Tick in 90 Seconds; No DEET, No Chemicals
According to Sherry Williams, Vice President, CureCeuticals' All-Natural Kills Ticks Specimen Drops start working on contact and kill a tick in about 90 seconds. The product contains no DEET, no chemicals, no synthetic ingredients and is completely safe.
2010-11-09
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Stanley Morgan & Associates Announces Quick Pay Program to Creditors for Holidays
2010-11-09
Stanley, Morgan & Associates, the country's leading collection association, announces plans to unveil its Quick Pay Program just in time for the holiday season.
Given present economical conditions, the reps at Stanley, Morgan & Associates understand time is money and having to wait for a check from your collection agency can mean the difference between expanding your wish list and keeping your doors open in the coming months. In an effort to place remittances in the clients' hands as quickly as possible, Stanley, Morgan & Associates announces the "Quick Pay Program" ...
The deVere Group Announces Sponsorship of Chris Foot's Historic South Pole Expedition - First Solo Polar Expeditionist to Travel 1392 Miles Unsupported and Unassisted
2010-11-09
The deVere Group, the world's largest independent financial consultancy group, was announced lead sponsor of Chris Foot in his quest to become the first polar expeditionist to travel 1392 miles solo unsupported and unassisted.
The deVere Group is sponsoring Chris GBP20,000 to aid the costs of the equipment for the expedition. In addition, deVere employees are raising money across the globe for Combat Stress.
This epic route is the only remaining conquest in Antarctica not to be claimed by an expeditionist. Chris will be in partnership with Combat Stress throughout ...
Joint pain linked to breast cancer drug not inflammatory arthritis or autoimmune disease
2010-11-08
Washington, DC -- A new study suggests joint complaints attributed to aromatase inhibitors (AI), popular breast cancer drugs, are not associated with inflammatory arthritis or autoimmune disease. Because of that, researchers say women who were primarily concerned about the threat of arthritis should be encouraged to continue taking the medication. The findings of the study will be presented Tuesday, Nov. 9 at the 74th Annual Scientific Meeting of the American College of Rheumatology in Atlanta, Georgia
For many post-menopausal women with breast cancer promoted by the ...
Georgetown study: Scleroderma dramatically under-diagnosed with commercial screening method
2010-11-08
Washington, DC -- New research from Georgetown University Medical Center (GUMC) suggests that up to 40 percent of scleroderma patients will not be correctly diagnosed with the disorder using a new automated commercial screening test. The findings of the study will be presented Wednesday, November 10th at the Annual Scientific Meeting of the American College of Rheumatology in Atlanta, Georgia.
The American College of Rheumatology recommends immunofluorescence antinuclear antibody (IF-ANA) testing to help detect the presence of scleroderma specific antinuclear antibodies. ...
Studying the metabolome of smokers, Lombardi researchers find early signs of damage
2010-11-08
Philadelphia, Pa. – Examining the blood "metabolomics" profile of smokers immediately after they had a cigarette revealed activation of pathways involved in cell death, inflammation, and other forms of systemic damage, say researchers at Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center.
They say their findings, presented at the Ninth AACR Frontiers in Cancer Prevention Research Meeting, is the best analysis for chemicals unequivocally produced by smoking and indicates the potential toll that carcinogens and toxins poise to ...
Study: Tai Chi relieves arthritis pain, improves reach, balance, well-being
2010-11-08
CHAPEL HILL, N.C. – In the largest study to date of the Arthritis Foundation's Tai Chi program, participants showed improvement in pain, fatigue, stiffness and sense of well-being.
Their ability to reach while maintaining balance also improved, said Leigh Callahan, PhD, the study's lead author, associate professor in the University of North Carolina at Chapel Hill School of Medicine and a member of UNC's Thurston Arthritis Research Center.
"Our study shows that there are significant benefits of the Tai Chi course for individuals with all types of arthritis, including ...
McMaster scientists turn skin into blood
2010-11-08
Hamilton, ON (November 7, 2010) – In an important breakthrough, scientists at McMaster University have discovered how to make human blood from adult human skin.
The discovery, published in the prestigious science journal Nature today, could mean that in the foreseeable future people needing blood for surgery, cancer treatment or treatment of other blood conditions like anemia will be able to have blood created from a patch of their own skin to provide transfusions. Clinical trials could begin as soon as 2012.
Mick Bhatia, scientific director of McMaster's Stem Cell ...
Hospital for Special Surgery scientists share advances in lupus and related conditions
2010-11-08
Hospital for Special Surgery physicians who focus on lupus, scleroderma and related conditions are traveling from New York City to Atlanta this week to share their recent findings at the 74th Annual Scientific Meeting of the American College of Rheumatology (ACR).
Special Surgery investigators will present advances that may influence the future of clinical care. Topics include prevention strategies for helping orthopedic patients avoid falls, quality of life in children with lupus, understanding joint pain caused by a commonly used breast cancer medication, lupus-related ...
New insect birth control strategy zaps cotton pests
2010-11-08
Using pests as part of an insect birth control program helps to get rid of them, UA researchers find. A new approach that combines the planting of pest-resistant cotton and releasing large numbers of sterile moths has virtually eliminated of the world's most destructive cotton pests from Arizona.
The novel control strategy, published in the Nov. 7 advance online publication of the journal Nature Biotechnology, has allowed growers to maintain high cotton yields without spraying insecticides to control pink bollworm.
"We are running the pesticide treadmill in reverse," ...
Statins don't prove useful for general pediatric lupus population
2010-11-08
ATLANTA, GA — Lupus puts children at higher risk for coronary artery disease when they become adults, but routinely using statins doesn't provide enough benefit to warrant their regular use in children and adolescents, according to the largest study of pediatric lupus patients to date.
Lupus is an autoimmune disease that causes widespread inflammation and organ damage. Children with lupus show early signs of atherosclerosis -- the fatty tissue buildup that is the precursor to clogged arteries. Previous research also indicates risk for heart attack and stroke in premenopausal ...
LAST 30 PRESS RELEASES:
Making lighter work of calculating fluid and heat flow
Normalizing blood sugar can halve heart attack risk
Lowering blood sugar cuts heart attack risk in people with prediabetes
Study links genetic variants to risk of blinding eye disease in premature infants
Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain
AI can pick up cultural values by mimicking how kids learn
China’s ecological redlines offer fast track to 30 x 30 global conservation goal
Invisible indoor threats: emerging household contaminants and their growing risks to human health
Adding antibody treatment to chemo boosts outcomes for children with rare cancer
Germline pathogenic variants among women without a history of breast cancer
Tanning beds triple melanoma risk, potentially causing broad DNA damage
Unique bond identified as key to viral infection speed
Indoor tanning makes youthful skin much older on a genetic level
Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy
The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025
Smarter tools for peering into the microscopic world
Applications open for funding to conduct research in the Kinsey Institute archives
Global measure underestimates the severity of food insecurity
Child survivors of critical illness are missing out on timely follow up care
Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial
University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage
Early relapse predicts poor outcomes in aggressive blood cancer
American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement
Clinical trial finds cannabis use not a barrier to quitting nicotine vaping
Supplemental nutrition assistance program policies and food insecurity
Switching immune cells to “night mode” could limit damage after a heart attack, study suggests
URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment
Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events
Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations
Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors
[Press-News.org] CureCeuticals Invents All-Natural Kills Ticks Drops: One Drop Kills Tick in 90 Seconds; No DEET, No ChemicalsAccording to Sherry Williams, Vice President, CureCeuticals' All-Natural Kills Ticks Specimen Drops start working on contact and kill a tick in about 90 seconds. The product contains no DEET, no chemicals, no synthetic ingredients and is completely safe.